Bvf Inc Day One Biopharmaceuticals, Inc. Transaction History

Bvf Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.72 - $17.9 $4.63 Million - $14.5 Million	-809,282 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$15.65 - $26.33 $15,681 - $26,382	-1,002 Reduced 0.12%	809,282 $13.6 Million
Q3 2021 Nov 15, 2021	SELL	$20.0 - $27.92 $2.17 Million - $3.03 Million	-108,691 Reduced 11.83%	810,284 $19.2 Million
Q2 2021 Aug 16, 2021	BUY	$19.0 - $23.69 $17.5 Million - $21.8 Million	918,975 New	918,975 $20.9 Million

181

84.2M

148K

218K

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $919M
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.